Volume 17, Number 2—February 2011
Research
Leptospirosis in Hawaii, USA, 1999–2008
Table 2
Sign, symptoms, and laboratory result |
No. (%) patients affected |
No. patients with data available |
Sign or symptom | ||
Fever | 187 (98) | 191 |
Myalgia | 162 (88) | 185 |
Headache | 156 (87) | 179 |
Nausea | 117 (68) | 173 |
Vomiting | 101 (59) | 172 |
Arthralgia | 73 (46) | 157 |
Diarrhea | 79 (46) | 171 |
Backache | 50 (34) | 146 |
Jaundice | 53 (33) | 163 |
Oliguria or anuria | 32 (21) | 152 |
Conjunctival suffusion | 30 (19) | 156 |
Nuchal rigidity | 23 (14) | 159 |
Pneumonia | 13 (8) | 154 |
Hepatosplenomegaly |
8 (6) |
140 |
Laboratory results | ||
Renal | ||
Hematuria | 78 (73) | 107 |
Proteinuria | 71 (68) | 105 |
Elevated creatinine (>1.5 mg/dL) | 60 (51) | 118 |
Elevated blood urea nitrogen (>20 mg/dL) | 68 (50) | 136 |
Hepatic | ||
Elevated alanine aminotransferase (>40 U/L) | 109 (74) | 147 |
Elevated total bilirubin (>1 mg/dL) | 85 (63) | 134 |
Hematologic | ||
Thrombocytopenia (<140 × 109/L) | 97 (66) | 146 |
Elevated leukocyte count (>10 × 109 cells/L) | 74 (48) | 155 |
Decreased hematocrit (<34%) | 56 (38) | 146 |
Page created: July 13, 2011
Page updated: July 13, 2011
Page reviewed: July 13, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.